Discover Tenders by Miscellaneous Pharmaceuticals Sector

Find the most relevant tenders for Miscellaneous Pharmaceuticals. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Miscellaneous Pharmaceuticals tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Miscellaneous Pharmaceuticals tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

70 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Somatropin Atc Code According To Who H01Ac01

Deadline: 31 Jul 2026

Germany

Ref. No.: 5977915

EMD:Ref Document

Bid Value: Ref Document

101 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of A So Called Open House Model For Medicinal Products With The Trade Name Acarizax R Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975947

EMD:Ref Document

Bid Value: Ref Document

101 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pegfilgrastim Atc Code According To Who L03Aa13

Deadline: 30 Apr 2026

Germany

Ref. No.: 5975224

EMD:Ref Document

Bid Value: Ref Document

9 Days Left

Deadline: 31 Jul 2026

Germany

Ref. No.: 5975023

EMD:Ref Document

Bid Value: Ref Document

101 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage Form Lse

Deadline: 10 May 2026

Germany

Ref. No.: 5968352

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acarbose Not In Standard Size 2

Deadline: 10 May 2026

Germany

Ref. No.: 5965414

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medicinal Product

Deadline: 10 May 2026

Germany

Ref. No.: 5965319

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V On Active Ingredients Medicines Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5901848

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Multiple Award Schedule

Deadline: 27 May 2029

United States

Ref. No.: 5883619

EMD:Ref Document

Bid Value: Ref Document

1132 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Combination Dolutegravir I Rilpivirine Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864985

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fosamprenavir Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864945

EMD:Ref Document

Bid Value: Ref Document

19 Days Left

Showing 13966 to 13980 of 14083 results

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!